Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Development of a novel nonantigenic dermal implant composed of human placental collagen.

Toman PD, Egbert BM, Thomas JA, DeLustro FA.

Plast Reconstr Surg. 2004 Mar;113(3):1015-20; discussion 1021-3.

PMID:
15108900
2.

Serological analysis of patients treated with a new surgical hemostat containing bovine proteins and autologous plasma.

Nelson PA, Powers JN, Estridge TD, Elder EA, Alea AD, Sidhu PK, Sehl LC, DeLustro FA.

J Biomed Mater Res. 2001;58(6):710-9.

PMID:
11745525
3.

Efficacy of a novel hemostatic agent in animal models of impaired hemostasis.

Prior JJ, Powers N, DeLustro F.

J Biomed Mater Res. 2000;53(3):252-7.

PMID:
10813765
4.

Evaluation of artecoll polymethylmethacrylate implant for soft-tissue augmentation: biocompatibility and chemical characterization.

McClelland M, Egbert B, Hanko V, Berg RA, DeLustro F.

Plast Reconstr Surg. 1997 Nov;100(6):1466-74.

PMID:
9385958
5.
6.

Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon.

Gabrielli A, Di Loreto C, Taborro R, Candela M, Sambo P, Nitti C, Danieli MG, DeLustro F, Dasch JR, Danieli G.

Clin Immunol Immunopathol. 1993 Sep;68(3):340-9.

PMID:
8370185
7.

Clinical use of injectable bovine collagen: a decade of experience.

Keefe J, Wauk L, Chu S, DeLustro F.

Clin Mater. 1992;9(3-4):155-62. Review.

PMID:
10171198
8.

Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives.

DeLustro F, Dasch J, Keefe J, Ellingsworth L.

Clin Orthop Relat Res. 1990 Nov;(260):263-79. Review.

PMID:
2225633
9.

Adoptive transfer of tsk skin fibrosis to +/+ recipients by tsk bone marrow and spleen cells.

Walker MA, Harley RA, DeLustro FA, LeRoy EC.

Proc Soc Exp Biol Med. 1989 Nov;192(2):196-200.

PMID:
2813452
10.

A retrospective study of antibodies against basement membrane antigens (type IV collagen and laminin) in patients with primary and secondary Raynaud's phenomenon.

Gabrielli A, Montroni M, Rupoli S, Caniglia ML, DeLustro F, Danieli G.

Arthritis Rheum. 1988 Nov;31(11):1432-6.

PMID:
3190785
11.

Osteoinduction by implants of demineralized allogeneic bone matrix is diminished in vitamin D-deficient rats.

Vandersteenhoven JJ, DeLustro FA, Bell NH, Turner RT.

Calcif Tissue Int. 1988 Jan;42(1):39-45.

PMID:
3129166
12.

Reaction to injectable collagen: results in animal models and clinical use.

DeLustro F, Smith ST, Sundsmo J, Salem G, Kincaid S, Ellingsworth L.

Plast Reconstr Surg. 1987 Apr;79(4):581-94.

PMID:
3823250
13.

Human monocyte modulation of endothelial cells and fibroblast growth: possible mechanism for fibrosis.

Kahaleh MB, DeLustro F, Bock W, LeRoy EC.

Clin Immunol Immunopathol. 1986 May;39(2):242-55.

PMID:
3516470
14.

The human immune response to reconstituted bovine collagen.

Ellingsworth LR, DeLustro F, Brennan JE, Sawamura S, McPherson J.

J Immunol. 1986 Feb 1;136(3):877-82.

PMID:
2416836
15.

A comparative study of the biologic and immunologic response to medical devices derived from dermal collagen.

DeLustro F, Condell RA, Nguyen MA, McPherson JM.

J Biomed Mater Res. 1986 Jan;20(1):109-20.

PMID:
3949821
16.

Mast cells and their degranulation in the Tsk mouse model of scleroderma.

Walker M, Harley R, Maize J, DeLustro F, LeRoy EC.

Proc Soc Exp Biol Med. 1985 Nov;180(2):323-8.

PMID:
4048170
17.

Cellular immunity to collagen and laminin in scleroderma.

Huffstutter JE, DeLustro FA, LeRoy EC.

Arthritis Rheum. 1985 Jul;28(7):775-80.

PMID:
4015724
18.

Comparison of inflammatory changes in established type II collagen- and adjuvant-induced arthritis using outbred Wistar rats.

Carlson RP, Datko LJ, O'Neill-Davis L, Blazek EM, DeLustro F, Beideman R, Lewis AJ.

Int J Immunopharmacol. 1985;7(6):811-26.

PMID:
4077344
19.

The absence of antibodies to type II collagen in established adjuvant arthritis in rats.

DeLustro F, Carlson RP, Datko LJ, DeLustro B, Lewis AJ.

Agents Actions. 1984 Jun;14(5-6):673-9.

PMID:
6475663
20.

Effect of gold salts, D-penicillamine and benoxaprofen on type II collagen-induced arthritis in rats.

Lewis AJ, Carlson RP, Chang J, DeLustro F.

Agents Actions. 1984 Jun;14(5-6):707-14.

PMID:
6433677
21.

Delayed-type hypersensitivity to elastase-soluble lung peptides in the tight-skin (Tsk) mouse.

DeLustro FA, Mackel AM, LeRoy EC.

Cell Immunol. 1983 Oct 1;81(1):175-9.

PMID:
6604585
22.

Neutrophil response to LIF: lack of glucocorticoid effect despite enhanced chemokinesis.

Lurie DP, DeLustro F, LeRoy EC.

Inflammation. 1983 Mar;7(1):49-56.

PMID:
6301986
23.

Immune response to laminin, a noncollagenous glycoprotein of basement membrane, in a syngeneic murine system.

Mackel AM, DeLustro F, LeRoy EC.

Proc Soc Exp Biol Med. 1982 Oct;171(1):98-108. No abstract available.

PMID:
7145942
24.
25.

Antibodies to collagen in scleroderma.

Mackel AM, DeLustro F, Harper FE, LeRoy EC.

Arthritis Rheum. 1982 May;25(5):522-31.

PMID:
6177323
26.

Characterization of the release of human monocyte regulators of fibroblast proliferation.

DeLustro F, LeRoy EC.

J Reticuloendothel Soc. 1982 Apr;31(4):295-305.

PMID:
7108871
27.

Immune response to connective tissue components of the basement membrane.

Mackel AM, DeLustro F, DeLustro B, Fudenberg HH, LeRoy EC.

Connect Tissue Res. 1982;10(3-4):333-43. Review.

PMID:
6218963
28.

Cell-mediated immunity to homologous basement membrane (type IV) collagen in C57BL/6 mice.

Mackel AM, DeLustro F, LeRoy EC.

Clin Immunol Immunopathol. 1981 Nov;21(2):204-16. No abstract available.

PMID:
6271429
29.

Three siblings with scleroderma (systemic sclerosis) and two with Raynaud's phenomenon from a single kindred.

Sheldon WB, Lurie DP, Maricq HR, Kahaleh MB, DeLustro FA, Gibofsky A, LeRoy EC.

Arthritis Rheum. 1981 May;24(5):668-76.

PMID:
6972218
30.

Human monocyte stimulation of fibroblast growth by a soluble mediator(s).

DeLustro F, Sherer GK, LeRoy EC.

J Reticuloendothel Soc. 1980 Dec;28(6):519-32. No abstract available.

PMID:
6970264
31.

Immune response to inactivated syngeneic mammary adenocarcinoma cells. II. Parameters of immunogenicity in DBA/2 mice.

DeLustro F, Haskill JS.

J Natl Cancer Inst. 1980 Jan;64(1):131-7. No abstract available.

PMID:
6928038
32.
33.

The importance of antibody and macrophages in spontaneous and drug-induced regression of the T1699 mammary adenocarcinoma.

Haskill JS, Key M, Radov LA, Parthenais E, Korn JH, Fett JW, Yamamura Y, DeLustro F, Vesley J, Gant G.

J Reticuloendothel Soc. 1979 Oct;26(4):417-25. No abstract available.

PMID:
316009
34.

In situ cytotoxic T cells in a methylcholanthrene-induced tumor.

DeLustro F, Haskill JS.

J Immunol. 1978 Sep;121(3):1007-9.

PMID:
308517
35.

Immunologic unresponsiveness of mouse spleen sensitized to allogenic tumors.

Argyris BF, DeLustro F.

Cell Immunol. 1977 Feb;28(2):390-403. No abstract available.

PMID:
139208
36.

Mechanism of mastocytoma-mediated suppression of lymphocyte reactivity.

DeLustro F, Argyris BF.

J Immunol. 1976 Dec;117(6):2073-80.

PMID:
136473
37.

Mastocytoma-medicated suppression of mixed lymphocyte culture and mitogen responsiveness.

DeLustro F, Argyris BF.

Cell Immunol. 1976 Jan;21(1):177-84. No abstract available.

PMID:
129285

Supplemental Content

Loading ...
Support Center